SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.66-2.4%2:11 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Edscharp3/9/2005 11:07:41 PM
  Read Replies (1) of 17367
 
Xoma management awarded bonuses

biz.yahoo.com

9-Mar-2005

Entry Material Agreement

Item 1.01. Entry into a Material Definitive Agreement
The Compensation Committee (the "Compensation Committee") of the Board of Directors (the "Board") of XOMA Ltd. (the "Company") and the Board, in connection with their annual review of the compensation of the Company's officers, have determined that management had met a percentage of the corporate objectives for 2004 in excess of the minimum required by the Management Incentive Compensation Plan established effective July 1, 1993 (as amended, the "MICP") in order to make awards thereunder. Accordingly, the Compensation Committee and the Board approved, as of March 7, 2005, the following cash and common share awards under the MICP to the following executive officers who were named in the Summary Compensation Table of the Company's 2004 Proxy Statement:

Clarence L. Dellio, former Senior Vice President and Chief Operating Officer, was awarded incentive compensation in the form of $25,000 and 9,995 common shares relating to performance in 2004; 1,115 common shares relating to performance in 2003; and 2,643 common shares relating to performance in 2002.

Patrick J. Scannon, M.D., Ph.D., Senior Vice President and Chief Scientific and Medical Officer, was awarded incentive compensation in the form of $40,630 and 18,319 common shares relating to performance in 2004; $21,771 relating to performance in 2003; and $17,160 relating to performance in 2002.

Peter B. Davis, Vice President, Finance and Chief Financial Officer, was awarded incentive compensation in the form of $32,834 and 13,290 common shares relating to performance in 2004; $19,018 relating to performance in 2003; and 2,299 common shares relating to performance in 2002.

Christopher J. Margolin, Vice President, General Counsel and Secretary, was awarded incentive compensation in the form of $32,253 and 13,661 common shares relating to performance in 2004; $19,693 relating to performance in 2003; and $14,160 relating to performance in 2002.

In addition, the Compensation Committee and the Board, in connection with their annual review of the compensation of the Company's Chief Executive Officer, John L. Castello, have determined that Mr. Castello had met a percentage of the corporate objectives for 2004 in excess of the minimum required by the CEO Incentive Compensation Plan (the "CICP") in order to make an award thereunder. Accordingly, the Compensation Committee and the Board approved, as of March 7, 2005, incentive compensation under the CICP to Mr. Castello in the form of 73,500 and 31,784 common shares relating to performance in 2004.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext